Role of Renal Sympathetic Nerves in GLP-1 (Glucagon-Like Peptide-1) Receptor Agonist Exendin-4-Mediated Diuresis and Natriuresis in Diet-Induced Obese Rats

被引:9
作者
Liu, Xuefei [1 ]
Patel, Kaushik P. [2 ]
Zheng, Hong [1 ]
机构
[1] Univ South Dakota, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA
[2] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2021年 / 10卷 / 21期
基金
美国国家卫生研究院;
关键词
glucagon-like peptide-1; neprilysin; obesity; renal nerve; sodium retention; BLOOD-PRESSURE; HEART-FAILURE; SODIUM-EXCRETION; HYPERTENSION; NEPRILYSIN; LIRAGLUTIDE; EXPRESSION; IMPACT; INJURY;
D O I
10.1161/JAHA.121.022542
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The gut-derived hormone GLP-1 (glucagon-like peptide-1) exerts beneficial effects against established risk factors for chronic kidney disease. GLP-1 influences renal function by stimulating diuresis and natriuresis and thus lowering arterial blood pressure. The role of the sympathetic nervous system has been implicated as an important link between obesity with elevated arterial pressure and chronic kidney disease. The primary aim of this study was to determine the contribution of renal sympathetic nerves on intrapelvic GLP-1-mediated diuresis and natriuresis in high-fat diet (HFD)-induced obese rats. Methods and Results Obesity was induced in rats by HFD for 12 weeks, followed by either surgical bilateral renal denervation or chronic subcutaneous endopeptidase neprilysin inhibition by sacubitril for a week. Diuretic and natriuretic responses to intrapelvic administration of the GLP-1R (GLP-1 receptor) agonist exendin-4 were monitored in anesthetized control and HFD rats. Renal GLP-1R expression and neprilysin expression and activity were measured. The effects of norepinephrine on the expression of GLP-1R and neprilysin in kidney epithelial LLC-PK1 cells were also examined. We found that diuretic and natriuretic responses to exendin-4 were significantly reduced in the HFD obese rats compared with the control rats (cumulative urine flow at 40 minutes, 387 +/- 32 versus 650 +/- 65 mu L/gkw; cumulative sodium excretion at 40 minutes, 42 +/- 5 versus 75 +/- 10 mu Eq/gkw, P<0.05). These responses in the HFD rats were restored after ablation of renal nerves (cumulative urine flow at 40 minutes, 625 +/- 62 versus 387 +/- 32 mu L/gkw; cumulative sodium excretion at 40 minutes, 70 +/- 9 versus 42 +/- 5 mu Eq/gkw, P<0.05). Renal denervation induced significant reductions in arterial pressure and heart rate responses to intrapelvic GLP-1 in the HFD rats. Renal denervation also significantly increased the GLP-1R expression and reduced neprilysin expression and activity in renal tissues from the HFD rats. Chronic subcutaneous neprilysin inhibition by sacubitril increased GLP-1-induced diuretic and natriuretic effects in the HFD rats. Finally, exposure of the renal epithelial cells to norepinephrine in vitro led to downregulation of GLP-1R expression but upregulation of neprilysin expression and activity. Conclusions These results suggest that renal sympathetic nerve activation contributes to the blunted diuretic and natriuretic effects of GLP-1 in HFD obese rats. This study provides significant novel insight into the potential renal nerve-neprilysin-GLP-1 pathway involved in renal dysfunction during obesity that leads to hypertension.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Dipeptidylpeptidase-4 (DPP-4) inhibitors are favourable to glucagon-like peptide-1 (GLP-1) receptor agonists: Yes
    Scheen, Andre J.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (02) : 126 - 131
  • [32] Glucagon-like peptide-1(GLP-1) receptor agonists: potential to reduce fracture risk in diabetic patients?
    Luo, Guojing
    Liu, Hong
    Lu, Hongyun
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (01) : 78 - 88
  • [33] The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution
    Zhao, Li
    Zhu, Chunfang
    Lu, Meng
    Chen, Chi
    Nie, Xiaomin
    Abudukerimu, Buatikamu
    Zhang, Kun
    Ning, Zhiyuan
    Chen, Yi
    Cheng, Jing
    Xia, Fangzhen
    Wang, Ningjian
    Jensen, Michael D.
    Lu, Yingli
    JOURNAL OF ENDOCRINOLOGY, 2019, 240 (02) : 271 - 286
  • [34] Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas
    Mcintyre, Roger S.
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (05) : 539 - 542
  • [35] Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia
    Teramoto, Shinichiro
    Miyamoto, Nobukazu
    Yatomi, Kenji
    Tanaka, Yasutaka
    Oishi, Hidenori
    Arai, Hajime
    Hattori, Nobutaka
    Urabe, Takao
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2011, 31 (08) : 1696 - 1705
  • [36] The endocrine disrupting potential of monosodium glutamate (MSG) on secretion of the glucagon-like peptide-1 (GLP-1) gut hormone and GLP-1 receptor interaction
    Shannon, Maeve
    Green, Brian
    Willars, Gary
    Wilson, Jodie
    Matthews, Natalie
    Lamb, Joanna
    Gillespie, Anna
    Connolly, Lisa
    TOXICOLOGY LETTERS, 2017, 265 : 97 - 105
  • [37] Antagonistic interaction between central glucagon-like Peptide-1 and oxytocin on diet-induced obesity mice
    Lee, Jeonghoon
    Moon, Haneul
    Lee, Hyunji
    Oh, Yunkyeong
    Kim, Changyeon
    Lee, Young Hee
    Kim, Min Sun
    NamKoong, Cherl
    Lee, Hee Won
    Kim, Jung Hee
    Choi, Hyung Jin
    HELIYON, 2020, 6 (10)
  • [38] Diet-induced obesity enhances postprandial glucagon-like peptide-1 secretion in Wistar rats, but not in diabetic Goto-Kakizaki rats
    Pinyo, Jukkrapong
    Hara, Hiroshi
    Hira, Tohru
    BRITISH JOURNAL OF NUTRITION, 2021, 126 (04) : 518 - 530
  • [39] Progesterone Receptor Membrane Component 1 Is a Functional Part of the Glucagon-like Peptide-1 (GLP-1) Receptor Complex in Pancreatic β Cells
    Zhang, Ming
    Robitaille, Melanie
    Showalter, Aaron D.
    Huang, Xinyi
    Liu, Ying
    Bhattacharjee, Alpana
    Willard, Francis S.
    Han, Junfeng
    Froese, Sean
    Wei, Li
    Gaisano, Herbert Y.
    Angers, Stephane
    Sloop, Kyle W.
    Dai, Feihan F.
    Wheeler, Michael B.
    MOLECULAR & CELLULAR PROTEOMICS, 2014, 13 (11) : 3049 - 3062
  • [40] Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiovascular Risk Management in Patients With Type 2 Diabetes Mellitus: A Systematic Review
    Parab, Panah
    Chaudhary, Priti
    Mukhtar, Sonia
    Moradi, Ali
    Kodali, Athri
    Okoye, Chiugo
    Klein, Dhadon
    Mohamoud, Iman
    Olanisa, Olawale O.
    Hamid, Pousette
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)